Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

By sjmartinez • November 9, 2023

Karpouzas GA, Szekanecz Z, Baecklund E, Mikuls TR, Bhatt DL, Wang C, Sawyerr GA, Chen Y, Menon S, Connell CA, Ytterberg SR, Mortezavi M. Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance. Ther Adv Musculoskelet Dis. 2023 Nov 6;15:1759720X231201047. doi: 10.1177/1759720X231201047. PMID: 37942277; PMCID: PMC10629315.

Tags: autoinflammatory conditions, DMARDs, Inflammation, outcome measures, Publications, Rheumatoid arthritis, Rheumatology

Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV

Grinspoon SK, Watanabe M, Ribaudo HJ, Bloomfield GS, Fichtenbaum CJ, Umbleja T, Chu SM, Fitch KV, Diggs MR, Zhao S, Looby SE, Currier JS, Aberg[...]

Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder

Appley M, Gray JR, Abdulrahim D, Bowden-Jones O. Grayken lessons: a multidisciplinary approach to care for a patient with severe ketamine use disorder. Addict Sci[...]

The Potential of Chronic Hypoxia Biomarkers to Guide Home Oxygen Therapy Prescription in COPD

Lacasse Y, Maltais F, Casaburi R. The Potential of Chronic Hypoxia Biomarkers to Guide Home Oxygen Therapy Prescription in COPD. Respir Care. 2026 Jan;71(1):97-102. doi:[...]